2017 American Transplant Congress » Concurrent Session: Novel Immunosuppression Regimens - Belatacept
Date: Tuesday, May 2, 2017
Time: 4:30pm-6:00pm
Location: E354b
Session Type: Concurrent Session
Meeting: 2017 American Transplant Congress
- 4:42pm-4:54pm
Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.
« View all sessions from the 2017 American Transplant Congress